213 related articles for article (PubMed ID: 24613476)
1. Thymosin β4 reduces IL-17-producing cells and IL-17 expression, and protects lungs from damage in bleomycin-treated mice.
Conte E; Iemmolo M; Fagone E; Gili E; Fruciano M; Genovese T; Esposito E; Cuzzocrea S; Vancheri C
Immunobiology; 2014 Jun; 219(6):425-31. PubMed ID: 24613476
[TBL] [Abstract][Full Text] [Related]
2. Thymosin β4 protects C57BL/6 mice from bleomycin-induced damage in the lung.
Conte E; Genovese T; Gili E; Esposito E; Iemmolo M; Fruciano M; Fagone E; Pistorio MP; Crimi N; Cuzzocrea S; Vancheri C
Eur J Clin Invest; 2013 Mar; 43(3):309-15. PubMed ID: 23320620
[TBL] [Abstract][Full Text] [Related]
3. Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis.
Conte E; Fagone E; Gili E; Fruciano M; Iemmolo M; Pistorio MP; Impellizzeri D; Cordaro M; Cuzzocrea S; Vancheri C
Oncotarget; 2016 Jun; 7(23):33841-54. PubMed ID: 27029074
[TBL] [Abstract][Full Text] [Related]
4. Effects of thymosin β4 and its N-terminal fragment Ac-SDKP on TGF-β-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis.
Conte E; Iemmolo M; Fruciano M; Fagone E; Gili E; Genovese T; Esposito E; Cuzzocrea S; Vancheri C
Expert Opin Biol Ther; 2015; 15 Suppl 1():S211-21. PubMed ID: 26098610
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of thymosin β4 in a mouse model of lung fibrosis.
Conte E; Genovese T; Gili E; Esposito E; Iemmolo M; Fruciano M; Fagone E; Pistorio MP; Crimi N; Cuzzocrea S; Vancheri C
Ann N Y Acad Sci; 2012 Oct; 1269():69-73. PubMed ID: 23045972
[TBL] [Abstract][Full Text] [Related]
6. 16,16-Dimethyl prostaglandin E2 efficacy on prevention and protection from bleomycin-induced lung injury and fibrosis.
Failla M; Genovese T; Mazzon E; Fruciano M; Fagone E; Gili E; Barera A; La Rosa C; Conte E; Crimi N; Cuzzocrea S; Vancheri C
Am J Respir Cell Mol Biol; 2009 Jul; 41(1):50-8. PubMed ID: 19059888
[TBL] [Abstract][Full Text] [Related]
7. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852
[TBL] [Abstract][Full Text] [Related]
8. Bleomycin-induced pulmonary fibrosis is attenuated by an antibody against KL-6.
Xu L; Yang D; Zhu S; Gu J; Ding F; Bian W; Rong Z; Shen C
Exp Lung Res; 2013 Aug; 39(6):241-8. PubMed ID: 23672275
[TBL] [Abstract][Full Text] [Related]
9. Asiatic acid ameliorates pulmonary fibrosis induced by bleomycin (BLM) via suppressing pro-fibrotic and inflammatory signaling pathways.
Dong SH; Liu YW; Wei F; Tan HZ; Han ZD
Biomed Pharmacother; 2017 May; 89():1297-1309. PubMed ID: 28320097
[TBL] [Abstract][Full Text] [Related]
10. Thymosin β4 Suppresses LPS-Induced Murine Lung Fibrosis by Attenuating Oxidative Injury and Alleviating Inflammation.
Tian Z; Yao N; Wang F; Ruan L
Inflammation; 2022 Feb; 45(1):59-73. PubMed ID: 34414534
[TBL] [Abstract][Full Text] [Related]
11. Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis.
Izumo T; Kondo M; Nagai A
Eur Respir J; 2009 Dec; 34(6):1444-51. PubMed ID: 19460787
[TBL] [Abstract][Full Text] [Related]
12. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
13. Mizoribine protects against bleomycin-induced lung injury.
Matsui K; Ueda H; Terada M; Azuma N; Okamura H; Sano H
Mod Rheumatol; 2010 Oct; 20(5):471-7. PubMed ID: 20490597
[TBL] [Abstract][Full Text] [Related]
14. Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis.
Cicko S; Grimm M; Ayata K; Beckert J; Meyer A; Hossfeld M; Zissel G; Idzko M; Müller T
Respir Res; 2015 Sep; 16(1):105. PubMed ID: 26369416
[TBL] [Abstract][Full Text] [Related]
15. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
[TBL] [Abstract][Full Text] [Related]
16. IL-10 inhibits inflammation but does not affect fibrosis in the pulmonary response to bleomycin.
Kradin RL; Sakamoto H; Jain F; Zhao LH; Hymowitz G; Preffer F
Exp Mol Pathol; 2004 Jun; 76(3):205-11. PubMed ID: 15126102
[TBL] [Abstract][Full Text] [Related]
17. Protection against bleomycin-induced lung injury by IL-18 in mice.
Nakatani-Okuda A; Ueda H; Kashiwamura S; Sekiyama A; Kubota A; Fujita Y; Adachi S; Tsuji Y; Tanizawa T; Okamura H
Am J Physiol Lung Cell Mol Physiol; 2005 Aug; 289(2):L280-7. PubMed ID: 15792964
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol alleviates bleomycin-induced lung injury in rats.
Sener G; Topaloğlu N; Sehirli AO; Ercan F; Gedik N
Pulm Pharmacol Ther; 2007; 20(6):642-9. PubMed ID: 17035056
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen sulfide protects against bleomycin-induced pulmonary fibrosis in rats by inhibiting NF-κB expression and regulating Th1/Th2 balance.
Cao H; Zhou X; Zhang J; Huang X; Zhai Y; Zhang X; Chu L
Toxicol Lett; 2014 Jan; 224(3):387-94. PubMed ID: 24269241
[TBL] [Abstract][Full Text] [Related]
20. Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice.
Saito F; Tasaka S; Inoue K; Miyamoto K; Nakano Y; Ogawa Y; Yamada W; Shiraishi Y; Hasegawa N; Fujishima S; Takano H; Ishizaka A
Am J Respir Cell Mol Biol; 2008 May; 38(5):566-71. PubMed ID: 18096870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
